Ed Fiorentino, Chairman and CEO of Crealta, formerly served as CEO of Actient Pharmaceuticals from the company’s formation in 2009 to its sale to Auxilium Pharmaceuticals in 2013. Prior to his role building Actient, Mr. Fiorentino was a former corporate officer and 22-year veteran of Abbott Laboratories (NYSE:ABT). His senior-level management experience at Abbott includes Corporate Vice President of Pharmaceutical Commercial Operations, where he was responsible for all U.S. sales, marketing and new product planning. He also served as Senior Vice President and President, Abbott Diabetes Care, leading Abbott’s global device business in this area. Mr. Fiorentino was Executive Vice President of TAP Pharmaceuticals, an Abbott joint venture with Takeda Pharmaceuticals.